guest opinion

The ACA’s Paradoxically Negative Impact on Middle-Income Oregonians

The author realizes that the Affordable Care Act will leave many people, including herself, worse off from a financial perspective
OPINION – September 19, 2012 -- When the Affordable Care Act (ACA) was first passed into law (2010) and then when it was largely upheld by this year’s SCOTUS ruling, I was anxiously anticipating that the ACA would not just be providing for improved benefits—but, that it would also be providing at least a degree of some much needed financial relief, through its premium tax credit and cost-sharing subsidy provisions. Read More >>

The ObamaCare Map

The author, who’s drawn an ObamaCare Map, asks what would happen if the Affordable Care Act is repealed after the November election, and suggests looking at the different routes these potential changes may take us
OPINION – September 12, 2012 -- During the last two years, I have become an avid supporter of ObamaCare. Due to several unforeseen health issues in our family I began taking a closer look at the Affordable Care Act. It had become very clear that the healthcare industry was not necessarily a good fit for everybody, especially for those who found themselves due to job changes between health insurance companies and coverage, or those with pre-existing conditions, or even worse those without any health insurance coverage at all. Read More >>

Regence: No Pity for Policyholders

With the imposition of an annual deductible of at least $2,500 for those not in a group plan, this customer might have to choose between underinsurance and uninsured
OPINION -- April 25, 2012 -- Regence Blue Cross of Oregon has notified individual subscribers that beginning in October they no longer will be able to buy coverage with a deductible lower than $2,500. The new plan also slashes benefits and raises co-payments and co-insurance.   Read More >>

Constitutionality of Patenting Gene Sequencing Reaches Supreme Court

Its decision could affect whether private companies can charge inflated prices for tests such as the BRCA gene for breast cancer
OPINION -- February 2, 2012 -- The Supreme Court is going to rule on the case of whether it is constitutional for biotech companies to be able to patent gene sequences. This will be a landmark patent case, since currently about 20 percent of the human genome is patented for various diseases. Read More >>

Public Health Will Benefit from New EPA Rules on Restricting Mercury

At the same time, we’re getting very close to the point of no return on climate change and global warming
OPINION:  January 5, 2012 – The EPA took a long-overdue action that Grist’s Dave Roberts compared to “an advance on par with getting lead out of gasoline” on December 21. The new EPA rules restrict mercury, one of the deadliest by-products of burning coal for electricity. Read More >>
Syndicate content

© Copyright 2013 by The Lund Report | Privacy Policy Development by: Roger Leigh | Design by:  Parachute Strategies